The optometry industry includes approximately 45,000 practice locations in the United States, generating an estimated $40 billion in combined annual revenue across vision care services, optical dispensing, medical eyecare, and contact lens fitting. It occupies a unique position in healthcare M&A because optometry practices generate revenue from two fundamentally different sources — clinical services and optical retail — creating a dual-revenue model that makes valuation more nuanced than in most healthcare businesses. PE-backed eyecare platforms have recognized this model's attractive economics and have become increasingly active acquirers, competing with traditional private-practice buyers for well-positioned practices.

The primary valuation method for optometry practices is Seller's Discretionary Earnings, or SDE. SDE adds the owner-OD's salary, personal benefits, depreciation, and non-recurring costs back to net income to show the total economic benefit of ownership. In optometry, the owner's compensation is often a combination of clinical salary, optical profit distributions, and personal expenses run through the practice. Common add-backs include the owner's clinical compensation, health insurance, retirement contributions, CE costs, and vehicle expenses. Optometry practices generally trade between 2.0x and 2.8x SDE, with the range driven primarily by optical capture rate, medical optometry revenue, and associate OD presence. A practice at 2.0x SDE is typically solo-OD, has optical capture below 55%, and generates most revenue from routine vision exams with limited medical billing. A practice at 2.8x has an associate OD, optical capture above 65%, medical optometry generating 25%+ of revenue, and a technology platform that supports comprehensive eyecare. The interplay between capture rate and medical revenue is unique to optometry — improvements in either stream compound through the practice's margin in ways that don't apply to other healthcare businesses.

Revenue multiples for optometry practices typically fall between 0.5x and 0.75x, reflecting the relatively strong margin profile that optical dispensing creates. A practice with high capture rates can generate net margins of 25–35%, which is substantially higher than most healthcare businesses, and this margin quality supports elevated revenue multiples. The caveat is that revenue multiples are misleading without understanding the capture rate and service mix — a practice collecting $1M with 70% optical capture has very different profitability than one collecting $1M with 40% capture. Buyers use revenue multiples for screening but always adjust for optical performance and medical billing composition before pricing.

For larger optometry practices generating $1M or more in annual EBITDA, PE-backed eyecare platforms use EBITDA multiples in the 4x to 6x range. These buyers are building multi-location eyecare networks and evaluate each practice's contribution to the platform's overall optical buying power, patient volume, and geographic coverage. Multi-location optometry groups with centralized optical procurement, established associate ODs, and medical optometry capabilities can command multiples above this range when strategic buyers compete.

The unique valuation factor that separates optometry from all other healthcare practices is the optical capture rate and its disproportionate impact on practice economics. In a medical or dental practice, revenue is generated entirely through clinical services. In optometry, the exam is often the lower-margin component, and the majority of practice profit comes from optical dispensing — frame sales, lens processing, and contact lens fills. This means that two practices with identical exam volumes and clinical revenue can have dramatically different profitability based solely on their optical performance. A practice seeing 6,000 comprehensive exams per year with 70% optical capture might generate $400,000 more in optical profit than one seeing the same exam volume with 45% capture. That profit difference flows directly through to SDE, multiplied by the practice's multiple, and can represent a $800,000–$1M difference in sale price. Buyers understand this math intimately, and optical capture is the first metric sophisticated acquirers analyze when evaluating an optometry practice. The challenge for many practice owners is that capture rates have been declining industry-wide as online retailers and subscription lens services compete for the optical fill — making practices that have maintained or grown their capture rates increasingly valuable and increasingly rare.

The optometry M&A market has become more competitive as PE capital has entered the space. Eyecare platforms backed by institutional investors are acquiring practices to build multi-state networks with centralized optical procurement, standardized clinical protocols, and shared administrative services. These platforms benefit from scale in optical buying power, which allows them to negotiate better frame and lens pricing than any individual practice can achieve. For sellers, this buyer competition means stronger offers for practices that meet platform criteria — associate OD presence, strong capture rates, medical billing capability, and modern technology. Solo-OD practices with declining capture rates and minimal medical optometry face a narrower buyer pool, as PE platforms focus their acquisition capital on practices that integrate efficiently into their existing operations. The gap between platform-ready and non-platform-ready practice valuations continues to widen.

Use our free calculator above to get your instant estimate, then track your value monthly with YourExitValue.